Tech Company Financing Transactions
Conatus Pharmaceuticals Funding Round
Conatus Pharmaceuticals, operating out of San Diego, secured $7.5 million from MPM Capital.
Transaction Overview
Company Name
Announced On
4/13/2011
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Series B
Investors
MPM Capital (James Scopa)
Proceeds Purpose
The additional investment by MPM enables Conatus to move ahead assertively with its confirming Phase 2b clinical trial of CTS-1027 started in January 2011 as well as allowing for a thorough evaluation of the development compounds of Idun Pharmaceuticals acquired in 2010.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
16745 West Bernardo Dr. 200
San Diego, CA 92127
USA
San Diego, CA 92127
USA
Phone
Website
Email Address
Overview
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Mento
Chief Operating Officer
Keith Marshall
VP - Finance
Michelle Vandertie
VP - R & D
Alfred Spada
Browse more venture capital transactions:
Prev: 4/12/2011: Scoutmob venture capital transaction
Next: 4/13/2011: Certify Data Systems venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs